Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 1 of 13 | Total 125 projects in this category
«   Page 1 2 3 4 5 6 7 8 9 10 11 12 13   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Starch and Allied Products from Maize With Co-Generation Plant

Maize is one of the best cereals after paddy and wheat. It is largely cultivated in the north and west India, though there is cultivation of Maize in the eastern and southern regions. Lot of commercial products manufactured from Maize which are used as the preparation of food based products or directly used for preparation of food, in the paper and many chemical industries.It is also used in textile and pharmaceutical industries. It has been observed that both starch and liquid glucose have good growth prospects in the years to come. There is very good scope for new entrants in the field of manufacturing of starch and allied products from Maize.
Plant capacity: 150 MT/DayPlant & machinery: Rs. 1305 Lacs
Working capital: Rs. 886 LacsT.C.I: Rs. 3200 Lacs
Return: 40.00%Break even: 21.90%
Add to Inquiry Add to Inquiry Basket

Ciprofloxacin

Drug and pharmaceutical industry is one of the basis industries of India. Recent moves in globalization and liberalization has affected this industry perhaps the highest. Pharmaceutical industry has close linkages with imports of material and technology of process know how and therefore with international economic. The industry started with manufacture of formulation from imported drugs in early 1940s. After independence with a view to ensure availability of good quality drugs at reasonable prices. Ciprofloxacin is used as anti bacterial drug or some time it is used as antibiotics. It is manufactured in India by few organized sectors as well as many private companies are engaged in the production of this product. There is very good indigenous demand as well as there is good export demand is available. So it can be concluded that any new entrepreneur may enter in this field with success.
Plant capacity: 300 Kgs./DayPlant & machinery: Rs. 44.0 Lakhs
Working capital: Rs. 130.0 LakhsT.C.I: Rs. 231.0 Lakhs
Return: 66.49%Break even: 35.01%
Add to Inquiry Add to Inquiry Basket

Sanitary Napkins

Sanitary Napkins is one of the item of non-woven textile. It may come under speciality textile group. According to industry observers, India?s health care industry is expected to grow around 13 % per annum. The product has very good export potentiality. The export of sanitary napkin has been increased 15% with in a span of ten years. The export of sanitary napkins from India were made to as many as 37 countries which includes countries like USA, Italy, France, Japan, Canada, Australia, Sweden, Germany and Middle East etc. Domestic demand is also increasing day by day. New entrepreneurs venture in to the project can get very good market.
Plant capacity: Plant & machinery: N/A
Working capital: N/AT.C.I: N/A
Return: N/ABreak even: N/A
Add to Inquiry Add to Inquiry Basket

Paracetamol

Paracetemol is an important intermediate in the manufacture of other pharmaceuticals like the antimalarial amodiaquine. Two types of paracetamol are commercially produced, namely powder and granules. The granules grade is called direct compressible product which is easier to use for making tablets. Three of the major manufacturers are in Andhra Pradesh? Srikrishna Pharma, Triton Laboratories and Srinivasa Agro industries and drug. The annual domestic requirement of paracetamol powder is about 10,000 tonnes. The total production is put at about 13,000 tonnes with the balance being exported. Paracetamol bulk drug project is considered as an ideal investment opportunity in small scale sector. There is good scope for new investment.
Plant capacity: 10 Tonnes/DayPlant & machinery: Rs. 10 Lakhs
Working capital: Rs. 17 LakhsT.C.I: Rs. 39 Lakhs
Return: 39.73%Break even: 63.23%
Add to Inquiry Add to Inquiry Basket

Surgical Methylated Spirit (Denatured Alcohol / Surgical Spirit)

Surgical Methylated Spirit is the special grade spirit, which is the mixture of castor oil, D.E.P. and some other chemicals. It has very good demand in pharmaceutical industries as well as in the hospitals. Average market growth for Surgical Methylated Spirit is 5 % per annum. Any new entrepreneur who will enter in the manufacturing of pharmaceutical grade methylated spirit will be successful.
Plant capacity: 10000 Litres/DayPlant & machinery: Rs. 69 Lakhs
Working capital: Rs. 96 LakhsT.C.I: Rs. 179 Lakhs
Return: 45.19%Break even: 60.81%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Industry

The progress of the pharmaceutical industry in India has been hampered by price and other controls. India?s pharmaceutical industry has made rapid progress in recent years. India is one of the world?s largest drug markets. There are about 350 large/medium units and about 8,000 small scale units which form the core of industry, with about 350 bulk drugs on therapeutic value for use in the production of formulation market. The industry provides direct employment to two lakhs people, indirect employment to another two people. There is good scope for new investment. Any entrepreneur can come in this project and get good domestic and as well as export market potential.
Plant capacity: -Plant & machinery: Rs. 19 Lakhs
Working capital: Rs. 54 LakhsT.C.I: Rs. 99 Lakhs
Return: 41.08%Break even: 53.83%
Add to Inquiry Add to Inquiry Basket

Clean Room for Pharmaceutical Unit

Clean room is an area where the air is totally pure in sense of free from microbial load. Clean room should be in hygenic condition. For maintaining clean rooms compressors and dehumidifier are needed. There is no pollution is evolve in this construction. There is a vast demand of biotechnology base products and specialty DNA base medicinal drugs, which are required a clean rooms. That?s why there is good marketing scope of the clean room designer.
Plant capacity: -Plant & machinery: Rs. 250 Lakhs
Working capital: Rs. 20 LakhsT.C.I: Rs. 700 Lakhs
Return: 20.00%Break even: 62.00%
Add to Inquiry Add to Inquiry Basket

Invert Sugar

Invert sugar is incorporated in products where loss of water must be avoided. It is used in the food industry, brewing industry, confectionery industry and as Humectant. A few public and private limited companies are manufacturing invert sugar. At present, there is no import or export of invert sugar in India. The present production is about 70,000 MT. There is an average production increase of 6 ? 10 % per annum with an average growth rate of 6 % . The estimated demand is about 93,440 MT. So there is good scope for new entrepreneurs.
Plant capacity: 10 MT /DayPlant & machinery: Rs. 156 Lakhs
Working capital: Rs. 145 LakhsT.C.I: Rs. 375 Lakhs
Return: 18.33%Break even: 68.62%
Add to Inquiry Add to Inquiry Basket

Ciprofloxacin

Drug and pharmaceutical industry is one of the basis industries of India. Recent moves in globalization and liberalization has affected this industry perhaps the highest. Pharmaceutical industry has close linkages with imports of material and technology of process know-how and therefore with international economic. The industry started with manufacture of formulation from imported drugs in early 1940s. After independence with a view to ensure availability of good quality drugs at reasonable prices. Ciprofloxacin is used as anti bacterial drug or some time it is used as antibiotics. It is manufactured in India by few organized sectors as well as many private companies are engaged in the production of this product. There is very good indigenous demand as well as there is good export demand is available. So it can be concluded that any new entrepreneur may enter in this field with success.
Plant capacity: 300 Kgs./DayPlant & machinery: Rs. 44.00 Lakhs
Working capital: Rs. 130.00 LakhsT.C.I: Rs. 231.00 Lakhs
Return: 66.49%Break even: 35.01%
Add to Inquiry Add to Inquiry Basket

Dextrin From Starch

Dextrin is a starch derivative. It is obtained as water-soluble carbohydrate produced by heat and acid depolymerization. It is mostly used in adhesive industry. Dextrin is used in adhesive application. These are used for envelope and labeling adhesives, adhesive for postage-stamp, gummed tape etc. Dextrin manufacture has very good scope for development in the small scale sector and especially in developing and agriculture based country like India. At present dextrin is running in short supply in the market. There is good scope for new investment in this project. The new entrepreneur can well venture in this field.
Plant capacity: 500 Kgs/DayPlant & machinery: -
Working capital: -T.C.I: -
Return: 39.71%Break even: 58.65%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 1 of 13 | Total 125 projects in this category
«   Page 1 2 3 4 5 6 7 8 9 10 11 12 13   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. Its various services are: Pre-feasibility study, New Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Preparation of Project Profiles and Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects and industry.

NPCS also publishes varies technology books, directory, databases, detailed project reports, market survey reports on various industries and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by Indian and overseas professionals including project engineers, information services bureau, consultants and consultancy firms as one of the input in their research.

^ Top

Products & Services

Others

Contact Us

My Account

Help

Payment Options

  • Credit Cards
  • Debit Cards
  • PayPal
  • Net Banking - (All Major Indian Banks)

We Process

  • Cards

Google Search


Search Project Report & Profiles





Subjects